Accelerate Diagnostics In... (AXDX)
Accelerate Diagnostics Statistics
Share Statistics
Accelerate Diagnostics has 25.21M shares outstanding. The number of shares has increased by 23.54% in one year.
| Shares Outstanding | 25.21M |
| Shares Change (YoY) | 23.54% |
| Shares Change (QoQ) | 5.76% |
| Owned by Institutions (%) | 1.31% |
| Shares Floating | 15.35M |
| Failed to Deliver (FTD) Shares | 357 |
| FTD / Avg. Volume | 0.92% |
Short Selling Information
The latest short interest is 473.08K, so 1.89% of the outstanding shares have been sold short.
| Short Interest | 473.08K |
| Short % of Shares Out | 1.89% |
| Short % of Float | 3.1% |
| Short Ratio (days to cover) | 7.77 |
Valuation Ratios
The PE ratio is -0.56 and the forward PE ratio is -0.73. Accelerate Diagnostics's PEG ratio is 0.01.
| PE Ratio | -0.56 |
| Forward PE | -0.73 |
| PS Ratio | 2.39 |
| Forward PS | 0.8 |
| PB Ratio | -0.5 |
| P/FCF Ratio | -1.16 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Accelerate Diagnostics Inc. has an Enterprise Value (EV) of 75.99M.
| EV / Earnings | -1.52 |
| EV / Sales | 6.5 |
| EV / EBITDA | -2.26 |
| EV / EBIT | -2.15 |
| EV / FCF | -3.14 |
Financial Position
The company has a current ratio of 0.71, with a Debt / Equity ratio of -1.13.
| Current Ratio | 0.71 |
| Quick Ratio | 0.62 |
| Debt / Equity | -1.13 |
| Total Debt / Capitalization | 866.52 |
| Cash Flow / Debt | -0.38 |
| Interest Coverage | -2.69 |
Financial Efficiency
Return on equity (ROE) is 0.89% and return on capital (ROIC) is -482.33%.
| Return on Equity (ROE) | 0.89% |
| Return on Assets (ROA) | -1.75% |
| Return on Capital (ROIC) | -482.33% |
| Revenue Per Employee | $109,327.1 |
| Profits Per Employee | $-467,710.28 |
| Employee Count | 107 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 3.15 |
Taxes
| Income Tax | -66K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -25.25% in the last 52 weeks. The beta is 0.55, so Accelerate Diagnostics's price volatility has been higher than the market average.
| Beta | 0.55 |
| 52-Week Price Change | -25.25% |
| 50-Day Moving Average | 1.14 |
| 200-Day Moving Average | 1.42 |
| Relative Strength Index (RSI) | 21.63 |
| Average Volume (20 Days) | 38.76K |
Income Statement
In the last 12 months, Accelerate Diagnostics had revenue of 11.7M and earned -50.05M in profits. Earnings per share was -2.15.
| Revenue | 11.7M |
| Gross Profit | 2.7M |
| Operating Income | -35.31M |
| Net Income | -50.05M |
| EBITDA | -33.57M |
| EBIT | -35.31M |
| Earnings Per Share (EPS) | -2.15 |
Balance Sheet
The company has 15.1M in cash and 63.35M in debt, giving a net cash position of -48.25M.
| Cash & Cash Equivalents | 15.1M |
| Total Debt | 63.35M |
| Net Cash | -48.25M |
| Retained Earnings | 0 |
| Total Assets | 28.56M |
| Working Capital | -8.96M |
Cash Flow
In the last 12 months, operating cash flow was -24.19M and capital expenditures 0, giving a free cash flow of -24.19M.
| Operating Cash Flow | -24.19M |
| Capital Expenditures | 0 |
| Free Cash Flow | -24.19M |
| FCF Per Share | -1.04 |
Margins
Gross margin is 23.12%, with operating and profit margins of -301.85% and -427.81%.
| Gross Margin | 23.12% |
| Operating Margin | -301.85% |
| Pretax Margin | -428.37% |
| Profit Margin | -427.81% |
| EBITDA Margin | -287% |
| EBIT Margin | -301.85% |
| FCF Margin | -206.82% |
Dividends & Yields
AXDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -290.54% |
| FCF Yield | -129.51% |
Analyst Forecast
The average price target for AXDX is $1, which is 35.1% higher than the current price. The consensus rating is "Hold".
| Price Target | $1 |
| Price Target Difference | 35.1% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jul 12, 2023. It was a backward split with a ratio of 1:10.
| Last Split Date | Jul 12, 2023 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -7.2 |
| Piotroski F-Score | 2 |